Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2003
11/27/2003WO2003097089A2 Attenuation of metapneumovirus
11/27/2003WO2003097087A1 Bcg vaccine and utilization thereof
11/27/2003WO2003097073A1 Combination of a beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders
11/27/2003WO2003097071A1 Hormone replacement therapy using a combination of conjugated estrogens and trimegestone
11/27/2003WO2003097069A1 Trimegestone and estrogens for treating post menopausal disorders
11/27/2003WO2003097062A1 Phenyl substituted imidazopyridines and phenyl substituted benzimidazoles
11/27/2003WO2003097059A1 Polymorphic forms of phenyl oxazolidinone derivatives
11/27/2003WO2003097055A2 Inhibitors of resistance to bacteria antibiotics
11/27/2003WO2003097054A1 Compositions and method for treating infection in cattle and swine
11/27/2003WO2003097052A2 Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
11/27/2003WO2003097050A2 A selective inos inhibitor and a pde inhibitor in combination for the treatment of respiratory diseases
11/27/2003WO2003097040A1 Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases
11/27/2003WO2003097009A1 Injection formulation
11/27/2003WO2003096989A2 Anti tubercular drug: compositions and methods
11/27/2003WO2003096977A2 Methods of treating hepatitis
11/27/2003WO2003096974A2 ORIENTIA TSUTSUGAMUSHI TRUNCATED RECOMBINANT OUTER MENBRANE PROTEIN (r47) AND (r56) VACCINES DIAGNOSTICS AND THERAPEUTICS FOR SCRUB TYPHUS AND HIV INFECTION
11/27/2003WO2003096965A2 Use of quinoline derivatives with anti-integrase effect and applications thereof
11/27/2003WO2003078361B1 Controlling chemical reactions by spectral chemistry and spectral conditioning
11/27/2003WO2003074547A3 Biologically active complex comprising alpha-lcatalbumin or a variant thereof, and a cofactor
11/27/2003WO2003067209A3 Ligands to enhance cellular uptake of biomolecules
11/27/2003WO2003066807A9 Method of inhibiting pathogenicity of infectious agents
11/27/2003WO2003066594A3 3-alkanoylamino-propionic acid derivatives used as inhibitors of integrin avss6
11/27/2003WO2003059881A3 Dna minor groove binding compounds
11/27/2003WO2003059270A3 Method for reducing morbidity and mortality in critically ill patients
11/27/2003WO2003051288A3 Mycobacterial vaccine
11/27/2003WO2003050252A3 Heme-regulated eukaryotic initiation factor 2 alpha kinase knockout mice and methods for use
11/27/2003WO2003039446A3 Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible no-synthase
11/27/2003WO2003035696A3 Humanized antibodies against icam-1, their production and uses
11/27/2003WO2003034275A3 Chimeric glycosylphosphatidylinositol containing peptides
11/27/2003WO2003032964A3 Gap junctions and endothelial-derived hyperpolarizing factor (edhf)
11/27/2003WO2003030824A3 Methods and compositions for treating dermal lesions
11/27/2003WO2003029276A3 Copolymers for suppression of autoimmune diseases, and methods of use
11/27/2003WO2003028656A3 Adjuvant compositions
11/27/2003WO2003024482B1 Crustaceans as production systems for therapeutic proteins
11/27/2003WO2003022209A3 Crystalline forms of valacyclovir hydrochloride
11/27/2003WO2003020222A3 PYRROLO[2,3-d]PYRIMIDINES FOR INHIBITING RNA-DEPENDENT RNA VIRAL POLYMERASE
11/27/2003WO2003018607A3 Process for preparing glycopeptide derivatives
11/27/2003WO2003010200A3 Nucleic acid encoding polypeptide involved in cellular entrance of the prrs virus
11/27/2003WO2003009836A3 New uses for 2-amino-2-propane-1,3-diols
11/27/2003WO2003009802A3 Synergistic antimicrobial ophthalmic and dermatologic preparations containing chlorite and hydrogen peroxide
11/27/2003WO2003008443A3 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
11/27/2003WO2003006425A3 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
11/27/2003WO2003005971A3 Tetracycline compounds having target therapeutic activities
11/27/2003WO2002097075B1 Capping enzyme of flavivirus and utilization of this protein in a process to test drugs with antiviral properties
11/27/2003WO2002092004A8 Use of hmg fragment as anti-inflammatory agents
11/27/2003WO2002086156A3 New polynucleotides and polypeptides of the ifn$g(a)-17 gene
11/27/2003WO2002085940A3 New polynucleotides and polypeptides of the erythropoietin gene
11/27/2003WO2002078730A3 Use of neublastin polypeptides for treating neuropathic pain
11/27/2003WO2002072020A3 Novel anti-adhesive compounds and uses thereof
11/27/2003WO2002070006A8 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
11/27/2003WO2002057242A3 Urea derivatives as integrin alpha 4 antagonists
11/27/2003WO2002049625A3 Compounds that affect cd83 expression, pharmaceutical compositions comprising said compounds and methods for identifying said compounds
11/27/2003US20030221209 Modified proteinase inhibitors
11/27/2003US20030221199 Surfactant protein D for the prevention and diagnosis of pulmonary emphysema
11/27/2003US20030220504 Forming a phenyl-thiazoles chemical intermediates for making antioxidants, ferrielectric liquid crystal dopant, picornaviral viricides, antiinflammatory agents, anti-asthma agents, and fibringoen antagonists
11/27/2003US20030220489 29 human secreted proteins
11/27/2003US20030220482 Novel peptide antagonist of CXCR4 derived from the N-terminus of the viral chemokine vMIP-II
11/27/2003US20030220478 Novel compounds
11/27/2003US20030220468 Modified forms of pharmacologically active agents and uses therefor
11/27/2003US20030220392 Prophylaxis of bacterial infections by administering 2'-(6-Chloropiperonyl)-3-(2,6-dichlorobenzyloxy)cinnamic acid and/or racemic mixtures, as antibiotics
11/27/2003US20030220382 Amines such as 2-((2-N,N-di-n-pentylamino)-indan-5-yl)amino-5 -nitro-benzoic acid, administered for prophylaxis of Alzheimer's disease
11/27/2003US20030220378 Oral administration of epothilones
11/27/2003US20030220375 N-biphenyl(substituted methyl) aminocycloalkane-carboxamide derivatives
11/27/2003US20030220372 Imidazole compounds as anti-inflammatory and analgesic agents
11/27/2003US20030220367 Administering a therapeutical carbamate derivative to a patient as prostaglandin IP (12 or PGI2) antagonists
11/27/2003US20030220362 Novel inhibitors of formation of advanced glycation endproducts (AGEs)
11/27/2003US20030220341 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
11/27/2003US20030220339 Heterocyclic arylsulfonamidobenzylic compounds
11/27/2003US20030220330 Anilinopyrimidine derivatives as JNK pathway inhibitors and compositions and methods related thereto
11/27/2003US20030220327 Cyanamide, alkoxyamino, and urea derivatives of 1,3-benzodiazephine as HIV reverse transcriptase inhibitors
11/27/2003US20030220315 Such as 3',3"-dibromo-4',4"-dimethoxy-5',5"-bis-(methoxycarbonyl)-1,1 -diphenylethene; for treating viral diseases/retroviruses
11/27/2003US20030220302 Combination of flunixin or the meglumine salt with a fluorinated chloramphenicol or thiamphenicol derivative antibiotic such as florfenicol
11/27/2003US20030220299 Use of substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds for treating hepatitis virus infections
11/27/2003US20030220297 Phosphorus-containing compounds and uses thereof
11/27/2003US20030220294 Cyclodextrin compositions and methods of treating viral infections
11/27/2003US20030220285 Expression vectors for stimulating an immune response and methods of using the same
11/27/2003US20030220272 Erythromycin type macrolide with a fused oxazolone ring
11/27/2003US20030220270 Mono-and disaccharide derivatives
11/27/2003US20030220248 Use of MP52 or MP121 for the treatment and prevention of diseases of the nervous system
11/27/2003US20030220239 Epitope sequences
11/27/2003US20030220228 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
11/27/2003US20030219898 Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof
11/27/2003US20030219875 Albumin fusion proteins
11/27/2003US20030219873 Self-assembling recombinant papillomavirus capsid proteins
11/27/2003US20030219864 Novel variants of RANKL protein
11/27/2003US20030219732 Adaptation sites of porcine reproductive and respiratory syndrome virus
11/27/2003US20030219727 Prodrugs of phosphonate nucleotide analogues
11/27/2003US20030219473 A lipid based cochelate formed of a purified soy- based phospholipid such as soy phosphatidylserine, and a multivalent cation selected from calcium, magnesium and zinc
11/27/2003US20030219463 Comprises cytotoxic lymphocytes which express CD3-antigen; cytokines
11/27/2003US20030219458 Multivalent vaccination using recombinant adenovirus
11/27/2003US20030219443 Mycobacterium tuberculosis superoxide dismutase
11/27/2003US20030219438 Human antibodies that bind human TNFalpha
11/27/2003US20030219424 Polynucleotide codes for amino acid sequences used for medical diagnosis, prophylaxis autoimmune diseases, as antiallergens or antitumor agents
11/27/2003US20030219411 Modulators of the function of FAS receptors and other proteins
11/27/2003US20030219375 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
11/27/2003CA2830619A1 Glucan-based vaccines
11/27/2003CA2812019A1 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome
11/27/2003CA2794297A1 Methods and compositions using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione or 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione for treatment and management of amyloidosis
11/27/2003CA2794060A1 Methods and compositions using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione for treatment and management of multiple myeloma
11/27/2003CA2752140A1 Methods and compositions using 3-(4-amino-1-oxo-1,3-dihydroisoindol-1-yl)-piperidine-2,6-dione for treatment and management of renal cancer
1 ... 1121 1122 1123 1124 1125 1126 1127 1128 1129 1130 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 1141 ... 1798